PMID- 26202804 OWN - NLM STAT- MEDLINE DCOM- 20160509 LR - 20150812 IS - 1399-0039 (Electronic) IS - 0001-2815 (Linking) VI - 86 IP - 3 DP - 2015 Sep TI - Meta-analysis of the human leukocyte antigen-G (HLA-G) 14 bp insertion/deletion polymorphism as a risk factor for preeclampsia. PG - 186-94 LID - 10.1111/tan.12627 [doi] AB - The non-classical major histocompatibility complex, human leukocyte antigen (HLA)-G, plays an important role in pregnancy. HLA-G mediates proper interaction between maternal immune cells and fetal trophoblasts invading the uterine wall, to ensure successful placental development and function. Several HLA-G gene variants have been shown to be associated with development of preeclampsia (PE), but the reported associations of the HLA-G 14 base pair (bp) insertion/deletion (I/D) polymorphism (rs66554220) with PE are inconsistent. In this meta-analysis of HLA-G 14 bp I/D in each member of the family triad, we estimated risk (odds ratio [OR], 95% confidence interval) of associations with PE based on nine published offspring, nine mother and three father case-control studies. No significant increased risk associations between PE and HLA-G 14 bp I/D were detected in any of the family triad members (offspring: OR = 1.08-1.21, P = 0.57-0.74; mothers: OR = 1.11-1.28, P = 0.07-0.44; fathers: OR = 1.09-1.65, P = 0.07-0.70). Of the 20 comparisons performed, 14 (70%) were non-heterogeneous and seven of these had zero heterogeneity (I(2) = 0%). Sensitivity treatment confirmed robustness for the overall lack of association for HLA-G 14 bp I/D. In subgroup analysis, significant association between HLA-G 14 bp I/D and PE was shown in offspring from primipara (OR = 1.66-1.95, P = 0.04) and European Caucasian pregnancies (OR = 1.37-2.03, P = 0.02-0.03). However, heterogeneity and sensitivity tests suggest that further investigation is needed to determine if HLA-G 14 bp I/D is involved in trophoblast HLA-G expression and PE development in these subgroups. CI - (c) 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. FAU - Pabalan, N AU - Pabalan N AUID- ORCID: 0000-0003-2069-5535 AD - Center for Research and Development, Angeles University Foundation, Angeles City, 2009, Philippines. AD - School of Medicine, Saint Louis University, Baguio City, 2600, Philippines. FAU - Jarjanazi, H AU - Jarjanazi H AD - Environmental Monitoring and Reporting Branch, Biomonitoring Unit, Ontario Ministry of the Environment and Climate Change, Ontario, M9P 3V6, Canada. FAU - Sun, C AU - Sun C AD - Department of Obstetrics and Gynecology, Haukeland University Hospital, Bergen, N-5021, Norway. FAU - Iversen, A C AU - Iversen AC AD - Centre of Molecular Inflammation Research, and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, N-7491, Norway. LA - eng PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't DEP - 20150722 PL - England TA - Tissue Antigens JT - Tissue antigens JID - 0331072 RN - 0 (HLA-G Antigens) SB - IM MH - *Base Pairing MH - Female MH - Gene Frequency MH - Genetic Association Studies MH - Genetic Heterogeneity MH - *Genetic Predisposition to Disease MH - HLA-G Antigens/*genetics MH - Homozygote MH - Humans MH - INDEL Mutation/*genetics MH - *Polymorphism, Genetic MH - Pre-Eclampsia/*genetics MH - Pregnancy MH - Risk Factors OTO - NOTNLM OT - human leukocyte antigen-G OT - meta-analysis OT - polymorphism OT - preeclampsia EDAT- 2015/07/24 06:00 MHDA- 2016/05/10 06:00 CRDT- 2015/07/24 06:00 PHST- 2015/02/14 00:00 [received] PHST- 2015/06/04 00:00 [revised] PHST- 2015/06/29 00:00 [accepted] PHST- 2015/07/24 06:00 [entrez] PHST- 2015/07/24 06:00 [pubmed] PHST- 2016/05/10 06:00 [medline] AID - 10.1111/tan.12627 [doi] PST - ppublish SO - Tissue Antigens. 2015 Sep;86(3):186-94. doi: 10.1111/tan.12627. Epub 2015 Jul 22.